About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Phoenix | 8,260 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,260 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 8,260 trials

CompletedHeart Focused Movement Effects on Cardiometabolic RiskThis study is designed as a two-group parallel randomized controlled trial (N=50) to test effects of 8-weeks of Qigong/Tai Chi (QTC) intervention compared to QTC plus HRVB on HRV…NCT05687240·Phoenix, Arizona CompletedThe Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision DisturbancesThe objectives of this study are: * To evaluate the efficacy of phentolamine mesylate 0.5% and 1.0% ophthalmic solution (Nyxol) in the treatment of night vision complaints…NCT01703559·Phoenix, Arizona CompletedA Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionThis study is designed to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in participants with platinum-resistant high-grade serous epithelial ovarian cancer…NCT04296890·Phoenix, Arizona and 88 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

CompletedSexual Functioning Study With AntidepressantsEffects of two depression medication on sexual functioningNCT00316160·Mesa, Arizona and 44 others

CompletedEffect of Supplementary Dietary Protein (21g Per Day) on Lean Mass and Strength in Sedentary, Adult VegetariansIt is possible that the lower protein intake in vegetarians and vegans may relate to a decrease in grip strength.NCT04076982·Phoenix, Arizona

CompletedBaroreflex Activation Therapy for Heart FailureThe purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy with the BAROSTIM NEO System…NCT02627196·Chandler, Arizona and 91 others

CompletedStudy of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)The purpose of this study is to assess the incidence of statin-associated myalgia (SAM) with treatment with PPD10558 versus atorvastatin in patients previously intolerant to…NCT01279590·Anniston, Alabama and 66 others

Enrolling by invitationA Study of Transcutaneous Electrical Stimulation As a Noxious Stimulus for the Glasgow Coma ScaleThe purpose of this study is to determine whether electrical stimulation can be used to replace physical stimulation to test awareness of patients with impaired consciousness.NCT06681779·Phoenix, Arizona

CompletedA Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy SurgeryThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 3 study to evaluate the efficacy and safety of the administration of multiple doses of…NCT02401750·Phoenix, Arizona and 4 others

CompletedA Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With OfatumumabTo assess whether participants treated with ofatumumab 20 mg subcutaneous (s.c.) administered once every 4 weeks (q4) can mount an adequate immune response to inactivated…NCT04667117·Phoenix, Arizona and 2 others

CompletedSelumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well selumetinib sulfate works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with MAPK…NCT03213691·Birmingham, Alabama and 109 others

CompletedAn 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic SubjectsThe purpose of this study is to evaluate the dose-response of different doses of CHF 781 Pressurized Metered Dose Inhaler (pMDI) on lung function and other clinical outcomes, to…NCT03084718·Birmingham, Alabama and 133 others

CompletedClinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual…NCT07016412·Dothan, Alabama and 56 others

Active not recruitingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK…NCT02568267·Phoenix, Arizona and 119 others

RecruitingTesting Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialThis phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has…NCT06500481·Phoenix, Arizona and 57 others

CompletedSPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's SyndromeThis is a randomized, placebo-controlled, study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome caused by a non-adrenal tumor.NCT05307328·Phoenix, Arizona and 11 others

TerminatedA Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart DiseaseThe Torcetrapib project was terminated on December 2, 2006 due to safety findings.NCT00134264·Alabaster, Alabama and 220 others

CompletedA Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long…NCT04294667·Birmingham, Alabama and 176 others

RecruitingStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO…NCT06079671·Birmingham, Alabama and 204 others

RecruitingA Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate CancerThe primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected…NCT06533644·Phoenix, Arizona and 22 others

PreviousPage 4 of 413Next

in Phoenix

Heart Diseasein Phoenix